Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth
The role will focus on identifying new opportunities and strengthening existing customer relationships to accelerate Ritedose’s continued growth.
READ MORE
IN THE NEWS
Ophthalmic
One Size No Longer Fits All in Pharmaceutical Manufacturing
Specialized CDMOs combine precision, agility and scale to meet the evolving needs of complex pharmaceutical manufacturing. This is production on purpose.
READ MORE
Patient Behavior Drives a Better Design
Learn how patient behavior can inform pharmaceutical product design, packaging and delivery to create safer, more intuitive therapies.
READ MORE
Hidden Contamination: What Preservative-Free Ophthalmic Patients Need to Know
Learn how Blow-Fill-Seal manufacturing supports ophthalmic sterility and why proper handling of single-use ophthalmic products is essential to preventing microbial contamination.
READ MORE
Why Reclosing a Single-Use Ophthalmic Vial Doesn’t Restore Sterility
A vial may look protected after being closed again, but sterility cannot be restored once a single-use ophthalmic vial has been opened.
READ MORE
Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing
Ritedose explores how purpose-driven pharmaceutical manufacturing strengthens quality, innovation and patient-centered care.
READ MORE
Eyedrop recall underscores need for quality focus
An FDA eye drop recall involving sterility concerns highlights the critical role of cGMP compliance, aseptic processing, and Blow-Fill-Seal technology in safe ophthalmic drug manufacturing.
READ MORE
Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing
– Collaboration showcases the Ritedose Center of Excellence as a global hub for advanced manufacturing education. – The Center of Excellence serves as a cornerstone of Ritedose’s broader commitment to workforce development and industry leadership.
READ MORE
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment.
READ MORE
FEATURED NEWS
RECEIVE THE LATEST NEWS
Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.